Advancing Regenerative Solutions for Lung Diseases and Respiratory Disorders
Pulmonary cell therapy is emerging as a promising strategy to restore lung function in patients with acute and chronic respiratory diseases. With the growing global burden of conditions like COPD, pulmonary fibrosis, ARDS, and COVID-related complications, regenerative therapies are being actively explored to repair damaged lung tissue, reduce inflammation, and improve oxygen exchange.
This session focuses on the latest innovations in cell-based therapies targeting pulmonary regeneration, immune modulation, and tissue remodeling.
Key Focus Areas:
Stem Cell Therapies for Lung Repair
Cell-Based Immunomodulation
Exosome and EV-Based Treatments
Cell Therapy for ARDS and COVID-19
Lung Bioengineering and 3D Models